EDIT · Editas Medicine, Inc.
$2.82
+0.01 (+0.36%)
At close · Aug 14
Market Cap
$433.10M
Shares
153.58M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Gilmore O’Neill | M.B., M.M.Sc. President and Chief Executive Officer | $2,353,655 |
| Linda Burkly | Executive Vice President and Chief Scientific Officer | $1,176,389 |
| Amy Parison | Senior Vice President and Chief Financial Officer | $821,655 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Gilmore O’Neill | M.B., M.M.Sc. President and Chief Executive Officer | $5,126,868 |
| Erick Lucera | Former Executive Vice President and Chief Financial Officer | $1,809,321 |
| Baisong Mei | M.D., Ph.D. Former Executive Vice President and Chief Medical Officer | $821,402 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Gilmore O’Neill | M.B., M.M.Sc. President and Chief Executive Officer | $2,392,309 |
| Erick Lucera | Former Executive Vice President and Chief Financial Officer | $2,215,616 |
| Michelle Robertson | Former Executive Vice President and Chief Financial Officer | $1,577,496 |
| Linda Burkly | Executive Vice President and Chief Scientific Officer | $1,537,048 |
| Bruce Eaton | Former Executive Vice President and Chief Business Officer | $1,305,388 |
| Baisong Mei | M.D., Ph.D. Former Executive Vice President and Chief Medical Officer | $1,141,405 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Gilmore O’Neill | M.B., M.M.Sc. President and Chief Executive Officer | $9,058,900 |
| Michelle Robertson | Former Executive Vice President and Chief Financial Officer | $3,422,086 |
| Baisong Mei | M.D., Ph.D. Senior Vice President and Chief Medical Officer | $3,010,747 |
| Bruce Eaton | Former Executive Vice President and Chief Business Officer | $2,735,748 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Michelle Robertson | Former Executive Vice President and Chief Financial Officer | $2,247,017 |
| Bruce Eaton | Former Executive Vice President and Chief Business Officer | $1,840,813 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Cynthia Collins | President and Chief Executive Officer | $14,489,736 |
| Judith Abrams | Chief Medical Officer | $2,825,252 |
| Charles Albright Ph.D | Executive Vice President and Chief Scientific Officer | $1,996,323 |
| Vic Myer | Former Chief Technology Officer | $1,608,717 |
| Eric Ek | Former interim Chief Financial Officer | $1,139,984 |
| Katrine S. Bosley | Former President and Chief Executive Officer | $661,240 |
| Andrew A. F. Hack | M.D., Ph.D. Former Chief Financial Officer | $70,187 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Katrine S. Bosley | Former President and Chief Executive Officer | $7,989,383 |
| Andrew A. F. Hack | M.D., Ph.D. Former Chief Financial Officer | $2,999,578 |
| Vic Myer | Former Chief Technology Officer | $2,455,739 |
| Charles Albright Ph.D | Executive Vice President and Chief Scientific Officer | $2,387,899 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Katrine S. Bosley | Former President and Chief Executive Officer | $6,091,500 |
| Andrew A. F. Hack | M.D., Ph.D. Former Chief Financial Officer | $2,051,456 |
| Charles Albright Ph.D | Executive Vice President and Chief Scientific Officer | $1,266,635 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Patrick Ellinor, M.D., Ph.D. | independent director (class I director) | Appointed | 2026-08-05 |
| Elliott Levy, M.D. | member of the Board of Directors (class I director) | Resigned | 2026-08-05 |
| David Scadden, M.D. | Class III director | Appointed | 2025-06-02 |
| Jessica Hopfield, Ph.D. | Class III director | Appointed | 2025-06-02 |
| Amy Parison | Senior Vice President, Chief Financial Officer and Treasurer | Appointed | 2025-03-20 |
| Erick Lucera | Executive Vice President, Chief Financial Officer | Resigned | 2025-03-20 |
| Jessica Hopfield | Chair of the Board | Appointed | 2024-12-12 |
| Emma Reeve | Board of Directors | Resigned | 2024-12-12 |
| Meeta Chatterjee | Board of Directors | Resigned | 2024-12-12 |
| Akshay Vaishnaw | Board | Resigned | 2024-06-27 |
| Erick J. Lucera | Executive Vice President and Chief Financial Officer | Appointed | 2023-05-17 |
| Elliot Levy, M.D. | independent director | Appointed | 2023-04-13 |
| Gilmore O'Neill, M.B., M.M.Sc. | class II director | Appointed | 2022-04-14 |
| Gilmore O'Neill, M.B., M.M.Sc. | President and Chief Executive Officer | Appointed | 2022-04-14 |
Key facts
CIK
1650664
CUSIP
28106W103
13F (30d)
226 filings
201 filers
Visit website
Investor relations